Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

By: 
Michelle Zhu
08/02/18, 05:36 pm

SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million investment allocation via the Startup SG Equity scheme.

Under the Startup SG Equity scheme, SSC supports early-stage startups across the technology and industry domain areas, and catalyses private-sector investments for startups via government equity co-investment.

The scheme announced its $100 million investment allocation in July 2017 to groom start-ups, and issued a call to its appointed partners to co-invest in the health & biomedical sciences and other fields.

In a Thursday announcement, Trendlines says it intends to invest in medical technology companies seeking Series A funding through its partnership with K2 Global. Both companies anticipate co-investing with SCC in more than 11 companies over the agreed partnership period of eight years.

They also consider the pipeline of deals originating from Trendlines Medical Singapore’s incubator, along with other companies that have strong development focus in Singapore, as “a rich environment for investment”.

Eric Loh, CEO of Trendlines Medical Singapore, sees the collaboration as one that leverages Trendlines’ experience and track record in identifying, incubating and grooming medical technology companies, while working closely with K2 Global to provide growth capital and support to help scale operations and facilitate global opportunities.

“This is an ideal relationship that will contribute substantial value to Singapore’s medical technology start-up ecosystem,” says Loh.

“Our participation in the Startup SG Equity program broadens our ability to develop early-stage medical technology companies in Singapore. Our collaboration with K2 Global will further strengthen our successful efforts in raising funds from strategic investors to boost the value of our portfolio companies. We expect numerous successful investment outcomes in the coming years,” adds Todd Dollinger, chairman of Trendlines Medical Singapore.

Shares in Trendlines close flat at 14 cents on Thursday. 

CapitaLand said to be acquiring Star Harbour International Center project in Shanghai for $2.5 bil

SINGAPORE (Oct 17): CapitaLand is said to be investing about RMB 12.79 billion ($2.54 billion) to acquire the Star Harbour International Center project in Hongkou, Shanghai, according to real estate online portal Mingtiandi. The group is said to be acquiring its most expensive real estate project yet in China from Shanghai Port Group, after the state-run developer announced on last Friday that it is planning to sell the property. CapitaLand has yet to make a statement regarding the acquisition. When The Edge Singapore reached out to CapitaLand for comments, the group said the tender h....
Read More >>

Few have made it where Tung Lok now treads: SAC

SINGAPORE (Oct 17): Since its founding in 1984, Tung Lok Restaurants (2000) has made a name for itself in the local F&B scene. From serving gourmet Chinese cuisine in its flagship Tung Lok Restaurant, it is now engaging the tastebuds of a younger generation and licensing its brands overseas. As at end March, Tung Lok operates as 43 F&B outlets with 24 directly owned, eight held by associates and 11 others under management. These are located in Indonesia, Japan, China, Vietnam and, of course, Singapore. The group’s operations can be segmented into three categories: restaurateur,....
Read More >>

Analysts put SPH on 'hold', but is the end of its earnings decline in sight?

SINGAPORE (Oct 17): Analysts across three brokerages – UOB Kay Hian, OCBC Investment Research, and CGS-CIMB Research – have “hold” recommendations on Singapore Press Holdings (SPH), as the group performed below expectations for FY18. SPH saw its full-year earnings fall 19.7% to $281.1 million for the FY18 ended August, from $350.1 million a year ago. However, this was mainly attributable to the absence of a one-off gain of $149.7 million a year ago from the divestment of a joint venture. FY18 operating revenue fell by 4.8% to $982.6 million, from $1.03 billion a year ago. See:....
Read More >>
Stars align for US banks to shine

(Oct 15): A decade after the global financial crisis, the landscape of the US financial services ind